so much "potential" upside in PRR, yes & to date all work undertaken is extremely encouraging....
but i don't think you can apply a "no brainer" title to any company heavily dependent on the outcome of clinical trials...
just my 2 cents having a dig at the thread title...
:-)
no brainer, page-9
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 3604 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 298 | 3 |
View Market Depth
| Last trade - 10.04am 31/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable